Published June 21, 1988
| Version v1
Patent
Treatment of arthritis, including rheumatoid arthritis, with radioactive isotopes
Creators
Description
A radioactive composition is described for the treatment of arthritis comprising, in combination, a ferric hydroxide or aluminum hydroxide aggregate suspension having a particle size of 3 to 20 microns, wherein a radionuclide is entrapped, the radionuclide being /sup 166/Holmium
Availability note (English)
U.S. Commissioner of Patents, Washington, D.C. 20231, USA, $.50.Additional details
Publishing Information
- Imprint Pagination
- vp.
- IPC:
- Int. Cl. A61K 43/00; A61N 5/10.
- IPC
- Int. Cl. A61K 43/00; A61N 5/10.
- Patent number
- US patent document 4,752,464/A/
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 20016092
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Non-conventional Literature
- Descriptors DEI
- ALUMINIUM HYDROXIDES; HOLMIUM 166; IRON HYDROXIDES; PARTICLE SIZE; RADIOTHERAPY; RHEUMATIC DISEASES; SUSPENSIONS; USES
- Descriptors DEC
- ALUMINIUM COMPOUNDS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; DAYS LIVING RADIOISOTOPES; DISEASES; DISPERSIONS; HOLMIUM ISOTOPES; HYDROGEN COMPOUNDS; HYDROXIDES; INTERMEDIATE MASS NUCLEI; IRON COMPOUNDS; ISOTOPES; MEDICINE; NUCLEI; ODD-ODD NUCLEI; OXYGEN COMPOUNDS; RADIOISOTOPES; RARE EARTH NUCLEI; SIZE; SKELETAL DISEASES; THERAPY; TRANSITION ELEMENT COMPOUNDS; YEARS LIVING RADIOISOTOPES